UMIN ID: UMIN000001526
Registered date:26/11/2008
Clinical trial of novel prostaglandin F2alpha derivative against glaucoma
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | glaucoma |
| Date of first enrollment | 2008/11/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Topical ocular hypotensive eye drops Topical ocular hypotensive eye drops |
Outcome(s)
| Primary Outcome | IOP reducing effect of eye drops against glaucomatous eyes. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | None |
Related Information
| Primary Sponsor | Departmet of Ophthalmology, Shimane University Faculty of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| tanito-oph@umin.ac.jp | |
| Affiliation | Shimane University Faculty of Medicine Department of Ophthalmology |
| scientific contact | |
| Name | Masaki Tanito |
| Address | Enya 89-1, Izumo Japan |
| Telephone | |
| Affiliation | Shimane University Faculty of Medicine Ophthalmology |